(0.30%) 5 115.19 points
(0.30%) 38 356 points
(0.34%) 15 982 points
(-0.92%) $83.08
(5.77%) $2.03
(0.36%) $2 355.70
(0.44%) $27.66
(4.02%) $959.15
(-0.22%) $0.933
(-0.38%) $10.98
(-0.54%) $0.796
(1.69%) $93.43
@ $66.88
発行日: 26 4月 2024 @ 22:30
リターン: 0.38%
前回のシグナル: 4月 26 - 03:48
前回のシグナル:
リターン: 0.60 %
Live Chart Being Loaded With Signals
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
Stats | |
---|---|
本日の出来高 | 258 984 |
平均出来高 | 882 104 |
時価総額 | 3.42B |
EPS | $0 ( 2024-03-06 ) |
次の収益日 | ( $-0.0500 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -559.42 |
ATR14 | $0.481 (0.72%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-31 | Sama Rinda | Buy | 28 000 | Common Stock |
2024-01-31 | Sama Rinda | Sell | 17 500 | Performance-Based Restricted Stock Units |
2024-01-31 | Noblett Karen | Buy | 27 500 | Common Stock |
2024-01-31 | Noblett Karen | Sell | 11 288 | Common Stock |
2024-01-31 | Noblett Karen | Sell | 15 000 | Performance-Based Restricted Stock Units |
INSIDER POWER |
---|
-1.65 |
Last 98 transactions |
Buy: 597 788 | Sell: 539 127 |
ボリューム 相関
Axonics Modulation 相関
10 最も負の相関 | |
---|---|
WKSP | -0.859 |
TRVG | -0.853 |
ACVA | -0.845 |
ACAD | -0.844 |
HCTI | -0.838 |
BRTX | -0.837 |
SOCL | -0.835 |
PATK | -0.831 |
EVLV | -0.83 |
KAII | -0.827 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Axonics Modulation 相関 - 通貨/商品
Axonics Modulation 財務諸表
Annual | 2023 |
収益: | $366.38M |
総利益: | $265.49M (72.46 %) |
EPS: | $-0.120 |
FY | 2023 |
収益: | $366.38M |
総利益: | $265.49M (72.46 %) |
EPS: | $-0.120 |
FY | 2022 |
収益: | $273.70M |
総利益: | $197.67M (72.22 %) |
EPS: | $-1.280 |
FY | 2021 |
収益: | $180.29M |
総利益: | $115.72M (64.18 %) |
EPS: | $-2.17 |
Financial Reports:
No articles found.
Axonics Modulation
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。